Post-earnings recap
Reported
Tue, Feb 27, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Teladoc Health's earnings report indicates significant challenges, particularly reflected in the EPS miss. The stock dropped 3.24% in response, suggesting investor concern over the company's current performance and lack of guidance. The management's defensive tone may signal ongoing difficulties in achieving profitability in the near term.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.76 | N/A | -85.36% |
| Revenue | N/A | N/A | N/A |
Management expressed concerns about current performance but remains committed to future growth strategies. They did not provide specific guidance for upcoming quarters.
Management acknowledged the challenges faced during the quarter.
They emphasized a focus on long-term growth despite short-term setbacks.